SARS-CoV-2-specific cellular responseBiomarker1 paper studies itHumans1LatestNature Aging·Apr 29Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infectionCohort study in peopleImmune responsePaper
Nature Aging·Apr 29Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infectionCohort study in peopleImmune responsePaper